CSIMarket
 


Anika Therapeutics Inc   (ANIK)
Other Ticker:  
 
 

ANIK's Free Cash Flow Growth by Quarter and Year

Anika Therapeutics Inc 's Free Cash Flow results by quarter and year




ANIK Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 3.64 0.48 4.47 2.59
III Quarter September 6.49 2.71 2.06 5.87
II Quarter June -8.29 3.09 4.29 3.57
I Quarter March -3.62 -1.87 -2.43 1.05
FY   -1.78 4.41 8.39 13.08



ANIK Free Cash Flow fourth quarter 2023 Y/Y Growth Comment
Anika Therapeutics Inc achieved in the fourth quarter 2023, above Company average Free Cash Flow surge of 657.92% year on year, to $ 3.64 millions.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 44 other companies have achieved higher Free Cash Flow growth. While Anika Therapeutics Inc ' s Free Cash Flow doubling of 657.92% ranks overall at the positon no. 1611 in the fourth quarter 2023.




ANIK Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 657.92 % -89.26 % 72.59 % -80.11 %
III Quarter September 139.48 % 31.55 % -64.91 % -41.59 %
II Quarter June - -27.97 % 20.17 % -34.73 %
I Quarter March - - - -87.59 %
FY   - -47.44 % -35.86 % -64.65 %

Financial Statements
Anika Therapeutics Inc 's fourth quarter 2023 Free Cash Flow $ 3.64 millions ANIK's Income Statement
Anika Therapeutics Inc 's fourth quarter 2022 Free Cash Flow $ 0.48 millions Quarterly ANIK's Income Statement
New: More ANIK's historic Free Cash Flow Growth >>


ANIK Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December -43.94 % -82.29 % 116.99 % -55.88 %
III Quarter September - -12.3 % -51.98 % 64.43 %
II Quarter June - - - 240 %
I Quarter March - - - -91.94 %
FY (Year on Year)   - -47.44 % -35.86 % -64.65 %




Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #45
Healthcare Sector #116
Overall #1611

Free Cash Flow Y/Y Growth Statistics
High Average Low
189.9 % -8.59 % -164.94 %
(June 30. 2014)   (Jun 30 2023)
Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #45
Healthcare Sector #116
Overall #1611
Free Cash Flow Y/Y Growth Statistics
High Average Low
189.9 % -8.59 % -164.94 %
(June 30. 2014)   (Jun 30 2023)

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Anika Therapeutics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
241.44 % 11.52 % -100 %
(Jun 30 2020)  


ANIK's IV. Quarter Q/Q Free Cash Flow Comment
In the IV. Quarter 2023 Anika Therapeutics Inc realized fall in Free Cash Flow from the third quarter by -43.94% to $ 3.64 millions, from $ 6.49 millions released a quarter before.

But that's not huge problem, as IV. Quarter Free Cash Flow generally seem to dip in this quarter.

Within Medical Equipment & Supplies industry 42 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Anika Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1331.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #43
Healthcare Sector #113
Overall #1331
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #43
Healthcare Sector #113
Overall #1331
Free Cash Flow Q/Q Growth Statistics
High Average Low
241.44 % 11.52 % -100 %
(Jun 30 2020)  


ANIK's IV. Quarter Q/Q Free Cash Flow Comment
In the IV. Quarter 2023 Anika Therapeutics Inc reported fall in Free Cash Flow sequentially by -43.94% to $ 3.64 millions, from $ 6.49 millions achived in the previous quarter.

As we analyse current slump in the quarter, we should assume, that commonly IV. Quarter Free Cash Flow emerge softer in contrast to the preciding period

Within Medical Equipment & Supplies industry 42 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Anika Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1331.


Anika Therapeutics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Free Cash Flow 12 Months Ending $ 3.64 $ -4.95 $ -8.72 $ 2.66 $ 4.41
Y / Y Free Cash Flow Growth (TTM) -17.46 % - - -82.28 % -67.44 %
Year on Year Free Cash Flow Growth Overall Ranking # 1722 # 1074 # 1161 # 687 # 1730
Seqeuential Free Cash Flow Change (TTM) - - - -39.67 % -47.51 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 1611 # 1227 # 1296 # 1019 # 1393




Cumulative Free Cash Flow growth Comment
Anika Therapeutics Inc showed decline, but improvement compare to trailing twelve month Free Cash Flow decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Anika Therapeutics Inc 's annual Free Cash Flow drop would be -17.46% year on year to $4 millions.

In the Healthcare sector 121 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 1074 to 1722.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
189.9 %
-8.59 %
-164.94 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 45
Healthcare Sector # 122
Overall # 1722

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
189.9 %
-8.59 %
-164.94 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 45
Sector # 116
S&P 500 # 1611
Cumulative Free Cash Flow growth Comment
Anika Therapeutics Inc showed decline, but improvement compare to trailing twelve month Free Cash Flow decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Anika Therapeutics Inc 's annual Free Cash Flow drop would be -17.46% year on year to $4 millions.

In the Healthcare sector 121 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 1074 to 1722.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
189.9 %
-8.59 %
-164.94 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 45
Healthcare Sector # 122
Overall # 1722

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
189.9 %
-8.59 %
-164.94 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 45
Sector # 116
S&P 500 # 1611




Other Free Cash Flow Growth
Medical Equipment & Supplies Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ANIK's Free Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ANIK's Competitors
Free Cash Flow Growth for Anika Therapeutics Inc 's Suppliers
Free Cash Flow Growth for ANIK's Customers

You may also want to know
ANIK's Annual Growth Rates ANIK's Profitability Ratios ANIK's Asset Turnover Ratio ANIK's Dividend Growth
ANIK's Roe ANIK's Valuation Ratios ANIK's Financial Strength Ratios ANIK's Dividend Payout Ratio
ANIK's Roa ANIK's Inventory Turnover Ratio ANIK's Growth Rates ANIK's Dividend Comparisons



Companies with similar Free Cash Flow drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2023
Elanco Animal Health Inc1,107.69%$ 1,107.692 millions
Surgery Partners Inc 769.44%$ 769.444 millions
Anika Therapeutics Inc 656.34%$ 656.341 millions
Tactile Systems Technology Inc 376.06%$ 376.057 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com